← Back to Search

Intervention group for Febrile Neutropenia

N/A
Waitlist Available
Research Sponsored by IDION Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 months
Awards & highlights

Study Summary

This trial is testing a device that may detect fever early in chemo patients, potentially helping with infection detection. #IDIONiTempShield

Eligible Conditions
  • Febrile Neutropenia

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Thermography
Secondary outcome measures
Thermography
Thermography
Other outcome measures
To analyze reimbursement for remote subject management.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Intervention groupExperimental Treatment1 Intervention
Subjects being treated for a cancer diagnosis with a plan for outpatient transplant or CAR-T therapy
Group II: Control GroupActive Control1 Intervention
Retrospective data from the control group comprised of 105 patients directly preceding the intervention group who are underwent stem cell transplant or CAR-T therapy. Such control group information will be obtained via a research data request. Only de-identified data will be obtained for these subjects.

Find a Location

Who is running the clinical trial?

IDION Inc.Lead Sponsor
~101 spots leftby Jun 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top